"I Think He's In There": After 10 Months Of Being Unable To Move Or Speak, Doctors Realized This Man Was Awake The Whole Time
"During this time, I realized there was something scarier than death. I thought I might be stuck like this forever." ...
Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update
Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug ...
Medscape2d
Successful Implementation of the National Institutes of Health Stroke Scale on a Stroke/Neurovascular Unit
Stroke-related neurological changes can occur ... Identification of motor weakness and ataxia can alert the staff to fall risk (Spilker et al., 1997). Despite evidence that the NIHSS is valid ...
Grace Therapeutics, Inc.: Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update
Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half of ...
Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered NimodipineNew Drug Application ...
Science Daily3d
Brain Injury News
The goal of this study was to assess the ... Sep. 5, 2024 — A study investigated the origin of ataxia in the brain of patients with stroke. A significant number of the stroke lesions in the ...
Grace Therapeutics, Inc.: Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine New Drug Application (NDA) Submission Expected in the First Half of 2025 PRI ...
He Could Hear Everything, But Couldn't Move Or Speak — This Man Survived Being "Locked-In" For 10 Months
"During this time, I realized there was something scarier than death. I thought I might be stuck like this forever." ...
Science Daily3d
Elder Care News
Jan. 30, 2025 — Propranolol, a beta blocker medication used for treating high blood pressure and preventing migraines, may lower ischemic stroke risk in women who experience migraines ...
pharmaphorum3d
Biogen’s Skyclarys is first EU drug for Friedreich’s ataxia
After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.
Medscape4d
Stroke/Cerebrovascular Disease
Sugar-sweetened beverages, the epidemiology of driving after an ICD, BP measurements, and massive EBM lesson in EVT for acute stroke are the topics John Mandrola, MD, discusses in today's podcast.
verywellhealth5d
Neurological Diseases
There are a wide variety of neurological diseases affecting the brain and nervous system. Understanding the specifics can help you navigate diagnostic tests and choose the best course of treatment.